Martin Currie LTD Zoetis Inc. Transaction History

Martin Currie LTD

$2.98 Billion
Q1 2024

A detailed history of Martin Currie LTD transactions in Zoetis Inc. stock. As of the latest transaction made, Martin Currie LTD holds 401,707 shares of ZTS stock, worth $70.5 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares

401,707

Previous 398,314 0.85%

Holding current value

$70.5 Million

Previous $78.6 Million 13.54%

% of portfolio

2.28%

Previous 2.81%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$165.67 - $199.94 $562,118 - $678,396	3,393 Added 0.85%	401,707 $68 Million
Q4 2023 Feb 13, 2024	SELL	$151.44 - $200.09 $3.71 Million - $4.9 Million	-24,496 Reduced 5.79%	398,314 $78.6 Million
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $1.53 Million - $1.77 Million	-9,165 Reduced 2.12%	422,810 $73.6 Million
Q2 2023 Aug 11, 2023	SELL	$160.94 - $186.23 $739,197 - $855,354	-4,593 Reduced 1.05%	431,975 $74.4 Million
Q1 2023 May 12, 2023	SELL	$145.48 - $175.02 $6.11 Million - $7.35 Million	-41,976 Reduced 8.77%	436,568 $72.7 Million

Q4 2022 Feb 10, 2023	BUY	$131.14 - $157.47 $49.1 Million - $58.9 Million	374,078 Added 358.09%	478,544 $70.1 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $291,241 - $358,528	-1,964 Reduced 1.85%	104,466 $15.5 Million
Q2 2022 Aug 11, 2022	SELL	$155.97 - $200.09 $162,364 - $208,293	-1,041 Reduced 0.97%	106,430 $18.3 Million
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $466,353 - $601,691	2,571 Added 2.45%	107,471 $20.3 Million
Q4 2021 Feb 11, 2022	SELL	$193.69 - $247.03 $347,867 - $443,665	-1,796 Reduced 1.68%	104,900 $25.6 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $293,210 - $324,809	1,549 Added 1.47%	106,696 $20.7 Million
Q2 2021 Aug 13, 2021	SELL	$155.9 - $187.99 $64,230 - $77,451	-412 Reduced 0.39%	105,147 $19.6 Million
Q1 2021 May 13, 2021	SELL	$144.0 - $169.39 $531,216 - $624,879	-3,689 Reduced 3.38%	105,559 $16.6 Million
Q4 2020 Feb 10, 2021	BUY	$157.07 - $174.35 $8.4 Million - $9.32 Million	53,450 Added 95.79%	109,248 $18.1 Million
Q3 2020 Nov 12, 2020	BUY	$137.1 - $165.37 $249,796 - $301,304	1,822 Added 3.38%	55,798 $9.23 Million
Q2 2020 Aug 14, 2020	BUY	$111.92 - $142.53 $650,031 - $827,814	5,808 Added 12.06%	53,976 $7.4 Million
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $275,478 - $430,906	-2,973 Reduced 5.81%	48,168 $5.67 Million
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $129,153 - $148,040	1,111 Added 2.22%	51,141 $6.86 Million
Q3 2019 Nov 14, 2019	BUY	$112.57 - $128.43 $59,549 - $67,939	529 Added 1.07%	50,030 $6.23 Million
Q1 2019 May 15, 2019	BUY	$81.56 - $100.67 $4.04 Million - $4.98 Million	49,501 New	49,501 $4.98 Million

Others Institutions Holding ZTS

# of Institutions

1,861

Shares Held

416M

Call Options Held

1.13M

Put Options Held

1.81M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Currie LTD, based on Form 13F filings with the SEC.

News

Stay updated on Martin Currie LTD with notifications on news.

Account

Martin Currie LTD Zoetis Inc. Transaction History